Medical Advance in Brazil Coincides with Diplomat's Health Crisis
Stephanie Al-Qaq, the UK ambassador to Brazil, contracted dengue fever in December 2024 and developed a rare, severe complication leading to acute liver failure. She received an emergency liver transplant in January 2025 through Brazil's public health system, a procedure involving collaboration between Brazilian and British surgical teams. Her recovery coincided with Brazil's approval of Butantan-DV, the world's first single-dose dengue vaccine developed by Instituto Butantan, which shows high efficacy and could significantly impact global health as dengue spreads due to climate change.
Key facts
- Stephanie Al-Qaq survived acute liver failure from dengue via liver transplant in Brazil
- Brazil approved Butantan-DV, the first single-dose dengue vaccine, in late 2025
- The vaccine shows 74.7% overall efficacy and 100% efficacy against hospitalizations
- Dengue is expanding globally due to climate change, with over 14 million cases in 2024
- Instituto Butantan plans to produce 60 million vaccine doses over two years
Entities
Institutions
- Instituto Butantan
- NHS
- SUS
- King's College Hospital
Locations
- Brazil
- Brasília
- UK
- São Paulo
- Latin America